Compass Therapeutics CMPX
NASDAQ CMPX
$0.92 -0.12 (-11.81%)
As of: Oct 1, 2026 · 3:33 PM EDT

Compass Therapeutics (CMPX) Return on Assets [ROA] (2019 - 2026)

Updated

Compass Therapeutics (CMPX) reported Return on Assets [ROA] of -41.02% for Q2 2026, up 12.59 percentage points from -53.61% a year earlier but down 5.62 percentage points from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Compass Therapeutics posted Return on Assets [ROA] of -40.47%, down 2.37 percentage points from FY2024.

  • Return on Assets [ROA] has declined for three consecutive years, though with a five-year change of +73.18 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -38.10% in FY2024 (-14.26 pp), -23.84% in FY2023 (-1.64 pp), -22.20% in FY2022 (+57.72 pp) and -79.92% in FY2021 (+33.73 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -53.61% in Q2 2025 and a high of -20.59% in Q1 2023.
  • Year over year, Return on Assets [ROA] has now increased in each of the last three quarters, with an average year-over-year change of -5.09 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2022 (a gain of 71.35 percentage points); the low point was Q2 2025 (a drop of 23.78 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -35.40% (Q1 2026), -31.72% (Q4 2025) and -40.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Compass Therapeutics 187.29 Mn 187.29 Mn - -41.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.02%
Mar 31, 2026 -35.40%
Dec 31, 2025 -31.72%
Sep 30, 2025 -40.29%
Jun 30, 2025 -53.61%
Mar 31, 2025 -43.05%
Dec 31, 2024 -36.38%
Sep 30, 2024 -32.50%
Jun 30, 2024 -29.83%
Mar 31, 2024 -28.58%
Dec 31, 2023 -26.00%
Sep 30, 2023 -23.29%
Jun 30, 2023 -23.25%
Mar 31, 2023 -20.59%
Dec 31, 2022 -23.96%
Sep 30, 2022 -30.30%
Jun 30, 2022 -24.13%
Mar 31, 2022 -22.34%
Dec 31, 2021 -37.66%
Mar 31, 2021 -57.00%
API Access

Compass Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CMPX&period=max&api_key=YOUR_API_KEY